SCHEMBL12468631

SCHEMBL12468631

Cn1c(C(N)=O)c(-c2ccccc2)c2cc(O)ccc21

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 4/20 0.48
SMN1; SMN2 Q16637 4/20 0.48
GAA P10253 2/20 0.48
HPGD P15428 2/20 0.48
KDM4E B2RXH2 1/20 0.48
ALDH1A1 P00352 1/20 0.48
CHEK1 O14757 2/20 0.47
WEE1 P30291 2/20 0.47
EGFR P00533 1/20 0.46
SRC P12931 1/20 0.46
KMT2A Q03164 4/20 0.43
RAB9A P51151 1/20 0.43
MEN1 O00255 3/20 0.41
ALOX5 P09917 1/20 0.41
F2RL3 Q96RI0 2/20 0.41
MAPT P10636 1/20 0.41
F2R P25116 1/20 0.41
NPSR1 Q6W5P4 1/20 0.41
PLA2G2A P14555 3/20 0.40
GFER P55789 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11412601 0.85 ACLY (0.53) KDM4EEGFRDPP4
SCHEMBL6017853 0.84 SMN1; SMN2 (0.53) LMNASMN1; SMN2GAAHPGDKDM4E
SCHEMBL11402837 0.81 F2RL3 (0.65) LMNASMN1; SMN2EGFRSRCKMT2A
SCHEMBL11265814 0.79 SMN1; SMN2 (0.51) LMNASMN1; SMN2GAAHPGDKDM4E
SCHEMBL21500661 0.77 MAP2 (0.47) LMNASMN1; SMN2HPGDKDM4EALDH1A1
SCHEMBL3884447 0.74 EGFR (0.46) LMNASMN1; SMN2GAAHPGDKDM4E
SCHEMBL27046200 0.74 WEE1 (0.54) LMNASMN1; SMN2GAAHPGDKDM4E
SCHEMBL8687160 0.73 ACLY (0.62) KDM4EEGFRKMT2ADPP4
SCHEMBL11224588 0.72 ACLY (0.54) KDM4EEGFRKMT2ADPP4
SCHEMBL8692416 0.72 ACLY (0.54) LMNASMN1; SMN2KDM4EEGFRKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2611804-A1 NOVEL COMPOUNDS AND COMPOSITIONS FOR THE INHIBITION OF NAMPT Forma TM, LLC. (US) 2013-07-10 EP claimed
WO-2012031197-A1 NOVEL COMPOUNDS AND COMPOSITIONS FOR THE INHIBITION OF NAMPT FORMA THERAPEUTICS, INC. (US) 2012-03-08 WO claimed